• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远处转移发生在胰腺癌遗传进化的晚期。

Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

机构信息

Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

出版信息

Nature. 2010 Oct 28;467(7319):1114-7. doi: 10.1038/nature09515.

DOI:10.1038/nature09515
PMID:20981102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3148940/
Abstract

Metastasis, the dissemination and growth of neoplastic cells in an organ distinct from that in which they originated, is the most common cause of death in cancer patients. This is particularly true for pancreatic cancers, where most patients are diagnosed with metastatic disease and few show a sustained response to chemotherapy or radiation therapy. Whether the dismal prognosis of patients with pancreatic cancer compared to patients with other types of cancer is a result of late diagnosis or early dissemination of disease to distant organs is not known. Here we rely on data generated by sequencing the genomes of seven pancreatic cancer metastases to evaluate the clonal relationships among primary and metastatic cancers. We find that clonal populations that give rise to distant metastases are represented within the primary carcinoma, but these clones are genetically evolved from the original parental, non-metastatic clone. Thus, genetic heterogeneity of metastases reflects that within the primary carcinoma. A quantitative analysis of the timing of the genetic evolution of pancreatic cancer was performed, indicating at least a decade between the occurrence of the initiating mutation and the birth of the parental, non-metastatic founder cell. At least five more years are required for the acquisition of metastatic ability and patients die an average of two years thereafter. These data provide novel insights into the genetic features underlying pancreatic cancer progression and define a broad time window of opportunity for early detection to prevent deaths from metastatic disease.

摘要

转移,即肿瘤细胞在起源器官以外的部位扩散和生长,是癌症患者死亡的最常见原因。这在胰腺癌中尤为如此,大多数患者被诊断为转移性疾病,很少对化疗或放疗有持续的反应。与其他类型的癌症患者相比,胰腺癌患者预后不佳是由于诊断较晚还是疾病较早扩散到远处器官尚不清楚。在这里,我们依赖于对七个胰腺癌转移灶的基因组测序所产生的数据来评估原发性和转移性癌症之间的克隆关系。我们发现,导致远处转移的克隆群体存在于原发性癌中,但这些克隆是从原始的、非转移性的亲代克隆中遗传进化而来的。因此,转移的遗传异质性反映了原发性癌中的情况。对胰腺癌遗传进化的时间进行了定量分析,表明从起始突变的发生到亲代、非转移性起始细胞的产生至少需要十年的时间。还需要至少五年的时间才能获得转移能力,此后患者平均两年内死亡。这些数据为胰腺癌进展的遗传特征提供了新的见解,并确定了一个广泛的早期检测机会窗口,以防止死于转移性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/b856bda63eec/nihms-236202-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/51ed888ef8b9/nihms-236202-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/9c3723481e59/nihms-236202-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/b856bda63eec/nihms-236202-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/51ed888ef8b9/nihms-236202-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/9c3723481e59/nihms-236202-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1038/3148940/b856bda63eec/nihms-236202-f0004.jpg

相似文献

1
Distant metastasis occurs late during the genetic evolution of pancreatic cancer.远处转移发生在胰腺癌遗传进化的晚期。
Nature. 2010 Oct 28;467(7319):1114-7. doi: 10.1038/nature09515.
2
The patterns and dynamics of genomic instability in metastatic pancreatic cancer.转移性胰腺癌中基因组不稳定性的模式和动态。
Nature. 2010 Oct 28;467(7319):1109-13. doi: 10.1038/nature09460.
3
Cancer: Genomic evolution of metastasis.癌症:转移的基因组进化
Nature. 2010 Oct 28;467(7319):1053-5. doi: 10.1038/4671053a.
4
Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.定量蛋白质组学揭示单一患者胰腺癌转移灶的异质性
Mol Cell Proteomics. 2014 Nov;13(11):2803-11. doi: 10.1074/mcp.M114.038547. Epub 2014 Jun 3.
5
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.源自细胞系和原发性肿瘤且具有不同转移活性的胰腺腺癌原位移植模型。
Pancreas. 2004 Oct;29(3):193-203. doi: 10.1097/00006676-200410000-00004.
6
Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy.永存癌症转移的复杂性:通过快速尸检获得的致死性转移性胰腺癌的遗传特征
Cancer Biol Ther. 2005 May;4(5):548-54. doi: 10.4161/cbt.4.5.1663. Epub 2005 May 12.
7
Untangling the genetics from the epigenetics in pancreatic cancer metastasis.解开胰腺癌转移中的遗传学和表观遗传学之谜。
Nat Genet. 2017 Feb 24;49(3):323-324. doi: 10.1038/ng.3798.
8
Pancreatic Cancer Metastases Harbor Evidence of Polyclonality.胰腺癌转移灶存在多克隆性证据。
Cancer Discov. 2015 Oct;5(10):1086-97. doi: 10.1158/2159-8290.CD-15-0120. Epub 2015 Jul 24.
9
Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies.胰腺外分泌腺癌的发育模式及后果观察。154例尸检结果。
Arch Surg. 1995 Feb;130(2):125-34. doi: 10.1001/archsurg.1995.01430020015001.
10
The evolutionary history of lethal metastatic prostate cancer.致死性转移性前列腺癌的进化史。
Nature. 2015 Apr 16;520(7547):353-357. doi: 10.1038/nature14347. Epub 2015 Apr 1.

引用本文的文献

1
Proteomic insights into early pancreatic ductal adenocarcinoma biology and screening.对早期胰腺导管腺癌生物学特性及筛查的蛋白质组学见解
Discov Oncol. 2025 Aug 11;16(1):1531. doi: 10.1007/s12672-025-03317-1.
2
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.从实验室到临床:癌症转移检测与治疗变革中的技术创新
Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8.
3
Epigenetic evolution and clinicopathological implications of distinct DNA methylation profiles in pancreatic ductal adenocarcinoma.

本文引用的文献

1
Development of personalized tumor biomarkers using massively parallel sequencing.利用大规模平行测序开发个体化肿瘤标志物。
Sci Transl Med. 2010 Feb 24;2(20):20ra14. doi: 10.1126/scitranslmed.3000702.
2
Signatures of mutation and selection in the cancer genome.癌症基因组中的突变和选择特征。
Nature. 2010 Feb 18;463(7283):893-8. doi: 10.1038/nature08768.
3
Advanced pancreatic carcinoma: current treatment and future challenges.晚期胰腺癌:当前的治疗方法和未来的挑战。
胰腺导管腺癌中不同DNA甲基化谱的表观遗传进化及临床病理意义
Sci Rep. 2025 Aug 6;15(1):28747. doi: 10.1038/s41598-025-13919-y.
4
Enhanced Tumor Diagnostics via Cyber-Physical Workflow: Integrating Morphology, Morphometry, and Genomic MultimodalData Analysis and Visualization in Digital Pathology.通过信息物理工作流程增强肿瘤诊断:在数字病理学中整合形态学、形态测量学和基因组多模态数据分析与可视化
Sensors (Basel). 2025 Jul 17;25(14):4465. doi: 10.3390/s25144465.
5
Pancreatic Cancer Mimicking Relapse of Autoimmune Pancreatitis: Case Reports.酷似自身免疫性胰腺炎复发的胰腺癌:病例报告
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0076. Epub 2025 Jul 15.
6
Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention.胰腺癌的转移异质性:靶向干预的机制与机遇
J Clin Invest. 2025 Jul 15;135(14). doi: 10.1172/JCI191943.
7
Nanomaterial-assisted pancreatic cancer theranostics.纳米材料辅助的胰腺癌诊疗
Regen Biomater. 2025 Jun 11;12:rbaf054. doi: 10.1093/rb/rbaf054. eCollection 2025.
8
Regulation of ubiquitin-proteasome system and its relative pathways in pancreatic adenocarcinoma.胰腺腺癌中泛素-蛋白酶体系统及其相关通路的调控
Bioimpacts. 2024 Oct 27;15:29993. doi: 10.34172/bi.29993. eCollection 2025.
9
H3K18 lactylation in pancreatic cancer: promising yet unproven ‒ a call for validation.胰腺癌中的H3K18乳酸化:前景虽好但未经证实——呼吁进行验证。
Clinics (Sao Paulo). 2025 Jun 24;80:100715. doi: 10.1016/j.clinsp.2025.100715.
10
Predicting Pancreatic Ductal Adenocarcinoma Occurrence Up to 10 Years in Advance Using Features of the Main Pancreatic Duct in Pre-Diagnostic CT Scans.利用诊断前CT扫描中主胰管的特征提前10年预测胰腺导管腺癌的发生
Cancers (Basel). 2025 Jun 4;17(11):1886. doi: 10.3390/cancers17111886.
Nat Rev Clin Oncol. 2010 Mar;7(3):163-72. doi: 10.1038/nrclinonc.2009.236. Epub 2010 Jan 26.
4
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.在胰腺癌小鼠模型中,抑制刺猬信号通路可增强化疗药物的递送。
Science. 2009 Jun 12;324(5933):1457-61. doi: 10.1126/science.1171362. Epub 2009 May 21.
5
Metastasis: from dissemination to organ-specific colonization.转移:从播散到器官特异性定植。
Nat Rev Cancer. 2009 Apr;9(4):274-84. doi: 10.1038/nrc2622.
6
The pathology and genetics of metastatic pancreatic cancer.转移性胰腺癌的病理学与遗传学
Arch Pathol Lab Med. 2009 Mar;133(3):413-22. doi: 10.5858/133.3.413.
7
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.通过全基因组分析揭示的人类胰腺癌核心信号通路。
Science. 2008 Sep 26;321(5897):1801-6. doi: 10.1126/science.1164368. Epub 2008 Sep 4.
8
Growth process of small pancreatic carcinoma: a case report with imaging observation for 22 months.小胰腺癌的生长过程:一例22个月影像学观察的病例报告
World J Gastroenterol. 2008 Mar 28;14(12):1958-60. doi: 10.3748/wjg.14.1958.
9
Comparative lesion sequencing provides insights into tumor evolution.比较性病变测序为肿瘤进化提供了见解。
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8. doi: 10.1073/pnas.0712345105. Epub 2008 Mar 12.
10
Pancreatic cancer.胰腺癌
Annu Rev Pathol. 2008;3:157-88. doi: 10.1146/annurev.pathmechdis.3.121806.154305.